BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 08, 2009
 |  BioCentury  |  Finance

Private vs. Public

Private vs. Public

Private company fundraising in Europe has outpaced the total raised by public companies over the past 5 quarters. Last year, funding for private European biotechs fell 21% to $1.1 billion from $1.4 billion...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >